Celyad Oncology SA (EBR: CYAD)
Belgium
· Delayed Price · Currency is EUR
0.692
-0.024 (-3.35%)
Dec 20, 2024, 4:30 PM CET
Celyad Oncology Market Cap
Celyad Oncology has a market cap or net worth of €28.67 million as of December 20, 2024. Its market cap has increased by 96.03% in one year.
Market Cap
28.67M
Enterprise Value
23.43M
Revenue
72.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.69
Market Cap Chart
Since July 4, 2013, Celyad Oncology's market cap has decreased from 101.99M to 28.67M, a decrease of -71.89%. That is a compound annual growth rate of -10.47%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
argenx SE | 36.50B |
UCB SA | 35.40B |
Financière de Tubize SA | 6.12B |
Fagron NV | 1.32B |
Ion Beam Applications SA | 388.11M |
Onward Medical N.V. | 218.23M |
Hyloris Pharmaceuticals SA | 148.40M |
Sequana Medical NV | 33.95M |